Clinical Trials

    A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum (GOG-3026)

    Investigator: Aparna Kamat

    Study Coordinator: Jaya Kamath

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT03673124

    Phone: 713.441.6616

    Protocol Number: Pro00021786

    Description


    The study evaluates the response to treatment with Ribociclib and Letrozole in patients with recurrent low grade serous cancer of the ovary, fallopian tube or peritoneum.